The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 15, 2015
Filed:
Mar. 24, 2010
Applicants:
Anna Berkenblit, Needham, MA (US);
Florence Marie Helene Binlich, Ville d'Avray, FR;
Paul Goss, Wellesley, MA (US);
Inventors:
Anna Berkenblit, Needham, MA (US);
Florence Marie Helene Binlich, Ville d'Avray, FR;
Paul Goss, Wellesley, MA (US);
Assignee:
WYETH LLC, New York, NY (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); A61K 31/435 (2006.01); A61K 31/4706 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4706 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01);
Abstract
An extended regimen for treatment of HER-2/neu overexpressed/amplified cancer is described, with involves delivering a course of neratinib therapy to HER-2/neu overexpressed/amplified cancer patients following the completion of surgical and adjuvant therapy. The neratinib regimen may be continued for upwards of twelve months to five years. Also provided are pharmaceutical kits designed to facilitate compliance with the regimen.